Skip to main content
EyeGene,Inc logo

EyeGene,Inc — Investor Relations & Filings

Ticker · 185490 ISIN · KR7185490000 KO Professional, scientific and technical activities
Open in API
Filings indexed 314 across all filing types
Latest filing 2021-04-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 185490

About EyeGene,Inc

https://eyegene.co.kr/en/

EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.

Recent filings

Filing Released Lang Actions
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short, formal notice regarding the suspension of stock trading ('주권매매거래정지') for a specific company due to a bonus issue ('무상증자'). It cites specific KOSDAQ market regulations. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or share issuance (which would be a different type of filing), it falls under the general regulatory filing category.
2021-04-12 Korean
증권신고서(지분증권)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details a capital increase through a rights offering (shareholder allocation followed by general public offering of unsubscribed shares). This document is a formal regulatory filing required for public offerings of securities, which falls under the category of capital and financing updates.
2021-04-12 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal 'Declaration of Voting Results' (정기주주총회결과) from a company's Annual General Meeting. It details the outcomes of various agenda items, including the approval of financial statements, election of directors, and the specific rejection of an auditor appointment due to quorum issues. This aligns perfectly with the definition for DVA (Declaration of Voting Results & Voting Rights Announcements).
2021-04-07 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Eutilex/Eyegene) detailing the acquisition of convertible bonds before their maturity date. This type of disclosure regarding capital structure changes, specifically the early redemption or acquisition of debt instruments, falls under the 'Capital/Financing Update' category as it relates to the company's financing activities and debt management.
2021-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (Annual General Meeting). It details the voting outcomes for agenda items such as financial statement approval, director and auditor appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of financial statements, audit opinions, and key financial metrics for the fiscal year. It is a standard regulatory filing in Korea (DART system) where a company announces the receipt and submission of its annual audit report. While it contains financial data, it is an announcement of the audit report's availability rather than the full 10-K annual report itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2020
2021-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.